FDA Issues Warning Letters to 115 Retailers, Naming Geek Bar and Elf Bar

Regulations by 2FIRSTS.ai
Dec.06.2024
FDA Issues Warning Letters to 115 Retailers, Naming Geek Bar and Elf Bar
FDA issues warning letters to 115 retailers for unauthorized e-cigarette sales, targeting popular brands linked to youth usage.

On December 5th, the US Food and Drug Administration (FDA) announced that it had issued warning letters to 115 retail entities for selling unauthorized e-cigarette products. The letters specifically mentioned the sale of disposable e-cigarette products produced by Chinese manufacturers and sold under well-known brand names such as Geek Bar Pulse, Geek Bar Skyview, Geek Bar Platinum, and Elf Bar.

FDA Issues Warning Letters to 115 Retailers, Naming Geek Bar and Elf Bar
List of 115 physical retail stores | Image source: US FDA

 

These warning letters are part of an ongoing enforcement action coordinated by the FDA with state partners aimed at identifying and cracking down on the unauthorized sale of e-cigarettes. The FDA has contracts with states, regions, or third-party agencies to assist in inspecting retail locations for compliance.

 

According to the results of the 2024 National Youth Tobacco Survey, 5.8% of current adolescent e-cigarette users reported having used products from the Geek Bar brand. Furthermore, after reviewing additional rapid surveillance data and preliminary data from the Population Assessment of Tobacco and Health Study, the FDA has also confirmed that this brand has a high level of appeal to young people.

 

The FDA closely monitors the tobacco industry for compliance with tobacco laws and regulations under the Federal Food, Drug, and Cosmetic Act, taking action when violations are found. Businesses that receive warning letters must respond within 15 working days, outlining corrective actions taken and plans to prevent future violations. Failure to promptly correct violations may result in further action by the FDA, such as litigation, seizures, and/or civil fines.

 

According to regulations, new tobacco products must obtain authorization from the FDA before they can be legally sold. Generally, products that have not been authorized face enforcement risks. As of now, the FDA has authorized 34 e-cigarette products and devices. These are currently the only e-cigarette products that can be legally sold in the United States. For more information on tobacco products that can be legally sold in the United States, you can refer to the FDA's searchable tobacco product database.

 

The following is the specific list:

 

FDA Issues Warning Letters to 115 Retailers, Naming Geek Bar and Elf Bar
List of 115 physical retail stores | Image source: US FDA

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.